102 related articles for article (PubMed ID: 21756288)
1. Binding studies and quantitative structure-activity relationship of 3-amino-1H-indazoles as inhibitors of GSK3β.
Caballero J; Zilocchi S; Tiznado W; Collina S; Rossi D
Chem Biol Drug Des; 2011 Oct; 78(4):631-41. PubMed ID: 21756288
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.
Dessalew N; Patel DS; Bharatam PV
J Mol Graph Model; 2007 Mar; 25(6):885-95. PubMed ID: 17018257
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR and molecular docking studies on 3-anilino-4-arylmaleimide derivatives as glycogen synthase kinase-3β inhibitors.
Akhtar M; Bharatam PV
Chem Biol Drug Des; 2012 Apr; 79(4):560-71. PubMed ID: 22168279
[TBL] [Abstract][Full Text] [Related]
4. Docking and quantitative structure-activity relationship of oxadiazole derivates as inhibitors of GSK3β.
Quesada-Romero L; Caballero J
Mol Divers; 2014 Feb; 18(1):149-59. PubMed ID: 24081608
[TBL] [Abstract][Full Text] [Related]
5. QSAR, docking, and CoMFA studies of GSK3 inhibitors.
García I; Fall Y; Gómez G
Curr Pharm Des; 2010; 16(24):2666-75. PubMed ID: 20642432
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Discovery of 1H-Indazole-3-carboxamides as a Novel Structural Class of Human GSK-3 Inhibitors.
Ombrato R; Cazzolla N; Mancini F; Mangano G
J Chem Inf Model; 2015 Dec; 55(12):2540-51. PubMed ID: 26600430
[TBL] [Abstract][Full Text] [Related]
7. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
8. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
Kamath S; Buolamwini JK
J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory mode of N-phenyl-4-pyrazolo[1,5-b] pyridazin-3-ylpyrimidin-2-amine series derivatives against GSK-3: molecular docking and 3D-QSAR analyses.
Xiao J; Guo Z; Guo Y; Chu F; Sun P
Protein Eng Des Sel; 2006 Feb; 19(2):47-54. PubMed ID: 16339768
[TBL] [Abstract][Full Text] [Related]
10. Insights into the interactions between maleimide derivates and GSK3β combining molecular docking and QSAR.
Quesada-Romero L; Mena-Ulecia K; Tiznado W; Caballero J
PLoS One; 2014; 9(7):e102212. PubMed ID: 25010341
[TBL] [Abstract][Full Text] [Related]
11. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Ashek A; Cho SJ
Bioorg Med Chem; 2006 Mar; 14(5):1474-82. PubMed ID: 16275103
[TBL] [Abstract][Full Text] [Related]
12. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
Zeng H; Zhang H; Jang F; Zhao L; Zhang J
Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
[TBL] [Abstract][Full Text] [Related]
14. Virtual docking approaches to protein kinase B inhibition.
Forino M; Jung D; Easton JB; Houghton PJ; Pellecchia M
J Med Chem; 2005 Apr; 48(7):2278-81. PubMed ID: 15801821
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory mode of indole-2-carboxamide derivatives against HLGPa: molecular docking and 3D-QSAR analyses.
Liu G; Zhang Z; Luo X; Shen J; Liu H; Shen X; Chen K; Jiang H
Bioorg Med Chem; 2004 Aug; 12(15):4147-57. PubMed ID: 15246091
[TBL] [Abstract][Full Text] [Related]
16. 3D QSAR for GSK-3beta inhibition by indirubin analogues.
Zhang N; Jiang Y; Zou J; Zhang B; Jin H; Wang Y; Yu Q
Eur J Med Chem; 2006 Mar; 41(3):373-8. PubMed ID: 16442187
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore modeling, quantitative structure-activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3beta inhibitory activities for cimetidine, hydroxychloroquine, and gemifloxacin.
Taha MO; Bustanji Y; Al-Ghussein MA; Mohammad M; Zalloum H; Al-Masri IM; Atallah N
J Med Chem; 2008 Apr; 51(7):2062-77. PubMed ID: 18324764
[TBL] [Abstract][Full Text] [Related]
18. Structural investigations of anthranilimide derivatives by CoMFA and CoMSIA 3D-QSAR studies reveal novel insight into their structures toward glycogen phosphorylase inhibition.
Saqib U; Kumar B; Siddiqi MI
SAR QSAR Environ Res; 2011; 22(5-6):411-49. PubMed ID: 21607894
[TBL] [Abstract][Full Text] [Related]
19. QSAR studies on imidazopyrazine derivatives as Aurora A kinase inhibitors.
Leng Y; Lu T; Yuan HL; Liu HC; Lu S; Zhang WW; Jiang YL; Chen YD
SAR QSAR Environ Res; 2012 Oct; 23(7-8):705-30. PubMed ID: 22971111
[TBL] [Abstract][Full Text] [Related]
20. 3D QSAR studies on GSK-3 inhibition by aloisines.
Zeng M; Jiang Y; Zhang B; Zheng K; Zhang N; Yu Q
Bioorg Med Chem Lett; 2005 Jan; 15(2):395-9. PubMed ID: 15603961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
